Funds holding Galera Therapeutics Inc
ISIN US36338D1081 · United States
- Fund holders
- 1
- Of which ETFs
- 0 1 other fund
- Value held
- 0.6 $
- Share of capital
- 0.0 % of 75.5M shares on Mar 16, 2026
A single tracked fund declares this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Diversified Equity Alpha Master Portfolio Master Investment Portfolio | 7 | 0.6 $ | 0.00 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 1 | 0 | 7 | 0.0 % |
| 2026Q2 | 1 | 0 | 7 | 0.0 % |
| 2026Q1 | 1 | 0 | 7 | 0.0 % |
| 2025Q4 | 1 | 0 | 7 | 0.0 % |
| 2025Q3 | 1 | 0 | 7 | 0.0 % |
| 2025Q2 | 1 | 0 | 7 | 0.0 % |
| 2025Q1 | 1 | 0 | 7 | 0.0 % |
| 2024Q4 | 1 | -4 | 7 | -100.0 % |
| 2024Q3 | 5 | -3 | 402,757 | -57.7 % |
| 2024Q2 | 8 | -1 | 951,078 | +8.9 % |
| 2024Q1 | 9 | -4 | 873,513 | -48.8 % |
| 2023Q4 | 13 | 1,707,458 |
Institutional managers
1 manager declares this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Ascentis Independent Advisors | 93 | 4 $ | as of Mar 31, 2026 |
Declared shareholders of Galera Therapeutics Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Ikarian Capital, LLC and 1 other | 0.00 % | 0 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Galera Therapeutics Inc". https://titelia.com/en/stocks/galera-therapeutics-inc-US36338D1081